Critical Path Institute Resources

June 16, 2025

New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects

The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic approach to r

June 13, 2025

Seeing as how this is a C-Path piece, I suppose it may be prudent to introduce myself to those in our community...

June 9, 2025

Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of...

June 4, 2025

C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program...

June 2, 2025

Critical Path Institute’s Critical Path for Lysosomal Diseases (CPLD) Consortium presents, Lysosomal Storage Disease Data Sh

May 29, 2025

SAN FRANCISCO and TUCSON, Ariz., May 29, 2025 — Critical Path Institute® (C-Path), a global nonprofit accelerating drug develop

May 27, 2025

C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is

May 22, 2025

Patient data is a key asset in understanding the progression of rare diseases...

May 20, 2025

Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.

May 15, 2025

May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...